Li H - Search Results

1

Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity.

Liu M, Li W, Larregieu CA, Cheng M, Yan B, Chu T, Li H, Mao SJ. Liu M, et al. Among authors: li w, li h. Mol Pharm. 2014 Jul 7;11(7):2305-12. doi: 10.1021/mp400759d. Epub 2014 Jun 3. Mol Pharm. 2014. PMID: 24830852

2

Development of intravenous lipid emulsion of tanshinone IIA and evaluation of its anti-hepatoma activity in vitro.

Chu T, Zhang Q, Li H, Ma WC, Zhang N, Jin H, Mao SJ. Chu T, et al. Among authors: li h. Int J Pharm. 2012 Mar 15;424(1-2):76-88. doi: 10.1016/j.ijpharm.2011.12.049. Epub 2011 Dec 31. Int J Pharm. 2012. PMID: 22226873

3

Development of intravenous lipid emulsion of α-asarone with significantly improved safety and enhanced efficacy.

Ma WC, Zhang Q, Li H, Larregieu CA, Zhang N, Chu T, Jin H, Mao SJ. Ma WC, et al. Among authors: li h. Int J Pharm. 2013 Jun 25;450(1-2):21-30. doi: 10.1016/j.ijpharm.2013.04.023. Epub 2013 Apr 20. Int J Pharm. 2013. PMID: 23608202

4

A novel immunoliposome mediated by CD123 antibody targeting to acute myeloid leukemia cells.

Wang Y, Liu F, Wang Q, Xiang H, Jin H, Li H, Mao S. Wang Y, et al. Among authors: li h. Int J Pharm. 2017 Aug 30;529(1-2):531-542. doi: 10.1016/j.ijpharm.2017.06.003. Epub 2017 Jun 3. Int J Pharm. 2017. PMID: 28583331

5

Growth-inhibitory and apoptosis-inducing effects of tanshinones on hematological malignancy cells and their structure-activity relationship.

Li H, Zhang Q, Chu T, Shi HY, Fu HM, Song XR, Meng WT, Mao SJ, Jia YQ. Li H, et al. Anticancer Drugs. 2012 Sep;23(8):846-55. doi: 10.1097/CAD.0b013e328351f896. Anticancer Drugs. 2012. PMID: 22495618

6

Development of 2-hydroxymethyl-3,5,6-trimethylpyrazine palmitate-loaded lipid emulsion: formulation, optimization, characterization, pharmacokinetics, biodistribution and pharmacodynamics.

Cao R, Li Q, Li H, Chu T, Jin H, Mao SJ. Cao R, et al. Among authors: li h, li q. J Drug Target. 2013 May;21(4):341-53. doi: 10.3109/1061186X.2012.751536. Epub 2013 Jan 12. J Drug Target. 2013. PMID: 23311747

7

Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia.

Liu FR, Jin H, Wang Y, Chen C, Li M, Mao SJ, Wang Q, Li H. Liu FR, et al. Among authors: li h, li m. Drug Deliv. 2017 Nov;24(1):882-890. doi: 10.1080/10717544.2017.1333170. Drug Deliv. 2017. PMID: 28574300 Free PMC article.

8

[Preparation of CD123 mono-antibody modified tanshinone ⅡA loaded immunoliposome and its in vitro evaluation].

Wang Y, Liu FR, Xiang HL, Qing H, Chen C, Mao SJ, Li H. Wang Y, et al. Among authors: li h. Zhongguo Zhong Yao Za Zhi. 2017 Jun;42(11):2085-2091. doi: 10.19540/j.cnki.cjcmm.20170428.002. Zhongguo Zhong Yao Za Zhi. 2017. PMID: 28822152 Chinese.

9

Development of eugenol-loaded submicron emulsion and its antiepileptic effect through regulating the oxidative stress.

Gao XF, Liu Q, Qing H, Mu KM, Zhang J, Zhang D, Li H, Mao SJ. Gao XF, et al. Among authors: li h. Int J Pharm. 2020 Sep 25;587:119724. doi: 10.1016/j.ijpharm.2020.119724. Epub 2020 Aug 2. Int J Pharm. 2020. PMID: 32755685

10

IFN-γ gene loaded human umbilical mesenchymal stromal cells targeting therapy for Graft-versus-host disease.

Li H, Liu Q, Gao X, Zhang D, Mao S, Jia Y. Li H, et al. Int J Pharm. 2021 Jan 5;592:120058. doi: 10.1016/j.ijpharm.2020.120058. Epub 2020 Nov 18. Int J Pharm. 2021. PMID: 33220383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121,735 results

Search Page

Filters